Seasonal Variation in Metabolic Syndrome Components: How Much Do They Influence the Diagnosis of Metabolic Syndrome?

Obesity and hypertension are increasing problems worldwide, resulting in an enormous economic burden to the society. The metabolic syndrome components (ie, central obesity, dyslipidemia, hyperglycemia, and hypertension) are used to identify individuals at high risk of developing cardiovascular disease and type 2 diabetes. The cause of the syndrome is not yet clear, but insulin resistance and dyslipidemia have been proposed. Emerging evidence suggest that increased visceral adipose tissue stimulates secretion of bioactive compounds that promote inflammation, oxidative stress, and impair lipid metabolism and vascular relaxation. Interestingly, all components of the metabolic syndrome display seasonal variation, and hence may influence diagnosis. The seasonal variability in metabolic components is partly explained by changes in climate and lifestyle factors (eg, physical activity and diet). The clinical role for seasonal variations in metabolic risk factors remains to be further elucidated. However, the new findings indicate that seasonal variation should be considered in diagnosis and management decisions.     

Digital Technology and Mobile Health in Behavioral Migraine Therapy: a Narrative Review

Purpose of Review

This article reviews the recent research and development of electronic health (eHealth) and, in particular, mobile health (mHealth) strategies to deliver behavioral treatment for migraine. Prospects for future development and research of mobile health in migraine are suggested.

Recent Findings

Advances in digital technology and mobile technology have led to an era where electronic and mobile approaches are applied to several aspects of healthcare. Electronic behavioral interventions for migraine seem to be acceptable and feasible, but efficacy measures are uncertain. Clinical trials on mHealth-based classical behavioral therapies, such as relaxation, biofeedback, and cognitive behavioral therapy are missing in the literature. Within mHealth, headache diaries are the most researched and scientifically developed. Still, there is a gap between commercially available apps and scientifically validated and developed apps.

Summary

Digital technology and mobile health has not yet lived out its potential in behavioral migraine therapy. Application of proper usability and functionality designs towards the right market, together with appraisal of medical and technological recommendations, may facilitate rapid development of eHealth and mHealth, while also establishing scientific evidence.

     

Inferior alveolar nerve lateralization and implant placement in atrophic posterior mandible

The aims of this article were to describe the surgical technique of the inferior alveolar nerve lateralization followed by implant installation by means of a clinical report and also to discuss the importance of an adequate surgical and prosthetic planning for atrophic posterior mandible rehabilitation.     

A systematic review and meta-analysis of the fully formed wisdom tooth as a radiological marker of adulthood

International Journal of Legal Medicine - Assessment of third molar development on dental radiograms is one of the most commonly used methods of forensic age estimation. Despite widespread use and...     

Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases

Purpose

To evaluate the safety and efficacy of selective internal radiation therapy (SIRT) in patients with unresectable liver metastases from neuroendocrine tumours (NETLMs).

Methods

This retrospective study included 40 patients with progressive NETLMs (22 women, 18 men, mean age 61.6 years) who underwent SIRT with ⁹⁰Y-labelled resin microspheres. Tumour response was evaluated according to the modified Response Evaluation Criteria in Solid Tumors (mRECIST) on CT or MR images. Medical records were reviewed.

Results

In the 40 patients, 54 evaluable SIRT procedures were performed, 33 to the right liver lobe (mean activity 1.31 GBq), 13 to the left lobe (mean activity 0.85 GBq), and 8 to both lobes (mean activity 1.61 GBq). Late follow-up imaging (mean 20 months) was performed after 44 of the treatments. Objective tumour response and disease control rates were 54 % (29 of 54 treatments) and 94 % (51 treatments), respectively, at the early follow-up examination (mean 3 months) and 34 % (15 treatments) and 57 % (25 treatments), respectively at the late follow-up examination. Mean overall survival from the first SIRT was 34,8 months and survival rates at 1, 2, 3 and 5 years were 76 %, 59 %, 52 % and 35 % respectively. Adverse effects were generally mild and easily manageable, except in one patient who died from radiation-induced liver failure. Of the 45 patients, 18 (45 %) had received peptide receptor radionuclide therapy (PRRT) prior to SIRT.

Conclusion

SIRT with ⁹⁰Y-labelled resin microspheres is a safe and effective treatment for patients with progressive NETLM, and also for those who have received prior PRRT.